Charles is a force to be reckoned with in the world of print and new media. From an interview with him in LowEndMac: ”His articles, features, and commentaries have appeared in more than 40 magazines, newspapers and websites in Canada, the US, the UK, and Australia. . . a columnist for The Halifax Daily News and the Saint John Telegraph Journal, Atlantic Fisherman, and news editor and columnist for Applelinks.com, a columnist and contributing editor for MacOpinion and PBCentral, as well as writing for Low End Mac.” Charles serves as the Senior Section Editor for the Science and Research section of BioNews Texas and contributes science-related articles on a daily basis.
Emperra GmbH of Potsdam, Germany, is expanding its Esysta diabetes management product systems with what it says is the first Bluetooth insulin pen. The Esysta BT smart insulin pen logs injected insulin ... Read more
Researchers at École Polytechnique Fédérale De Lausanne (EPFL), a technical university in Switzerland whose students, professors, and staff from more than 120 countries are focused on three missions — teaching, research, and ... Read more
A research team of students at Hebrew University of Jerusalem (HUJI) in Israel developed an innovative technology that than helps prevent the development of foot ulcers associated with diabetic ... Read more
Our human constitutions are to a substantial degree, determined by genetics we inherit from our antecedents and the dietary habits of and foods available to one’s forbears have substantial ... Read more
Neurology researchers Shannon Macauley, PhD, David Holtzman, MD, and colleagues at Washington University School of Medicine in St. Louis, have discovered a unique connection between Alzheimer’s disease and diabetes. ... Read more
A nationwide study being conducted by Georgetown University neurologist R. Scott Turner, MD, PhD, has unexpectedly discovered that a large proportion of participants have previously undiagnosed glucose intolerance, even ... Read more
The U.S. Food and Drug Administration on Wednesday, March 25 expanded the approved use for Eylea (aflibercept) injections for treatment of diabetic retinopathy in patients with diabetic macular edema. ... Read more